FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087080946> ?p ?o ?g. }

• W3087080946 endingPage "141" @default.
• W3087080946 startingPage "136" @default.
• W3087080946 abstract "Background: Hereditary angioedema (HAE) due to C1 inhibitor (C1INH) deficiency is characterized by recurrent attacks of edema of the skin and mucosal tissues. Symptoms usually present during childhood (mean age at first attack, 10 years). Earlier symptom onset may predict a more severe disease course. Subcutaneous (SC) C1INH is indicated for routine prophylaxis to prevent HAE attacks in adolescents and adults. We analyzed the long-term efficacy of C1INH (SC) in subjects ≤17 years old treated in an open-label extension (OLE) of the pivotal phase III Clinical Study for Optimal Management of Preventing Angioedema with Low-Volume Subcutaneous C1 Inhibitor Replacement Therapy (COMPACT) trial. Methods: Eligible subjects (age ≥6 years, with ≥4 attacks over 2 consecutive months before entry into the OLE or placebo-controlled COMPACT trial) were treated with C1INH (SC) 40 or 60 IU/kg twice weekly for 52–140 weeks. Subgroup analyses by age (≤17 vs. >17 years) were performed for key efficacy endpoints. Results: Ten subjects were ≤17 years old [mean (range) age, 13.3 (8–16) years, 3 subjects <12 years old; exposure range, 51–133 weeks]. All 10 pediatric subjects experienced ≥50% reduction (mean, 93%) in number of attacks versus the prestudy period, with a 97% reduction in the median number of attacks/month (0.11). All subjects had <1 attack/4-week period and 4 had <1 attack/year (1 subject was attack free). No subject discontinued treatment due to a treatment-related adverse event. Conclusions: Data from pediatric subjects treated with C1INH (SC) for up to 2.55 years and adult subjects revealed similar efficacy. C1INH (SC) is effective and well tolerated as long-term prophylaxis in children, adolescents, and adults with HAE." @default.
• W3087080946 created "2020-09-25" @default.
• W3087080946 creator A5000365272 @default.
• W3087080946 creator A5000815038 @default.
• W3087080946 creator A5005153960 @default.
• W3087080946 creator A5009663015 @default.
• W3087080946 creator A5023011562 @default.
• W3087080946 creator A5051845249 @default.
• W3087080946 creator A5052789300 @default.
• W3087080946 creator A5053619303 @default.
• W3087080946 creator A5058969386 @default.
• W3087080946 creator A5073049397 @default.
• W3087080946 creator A5074941284 @default.
• W3087080946 creator A5084508450 @default.
• W3087080946 date "2020-09-01" @default.
• W3087080946 modified "2023-10-18" @default.
• W3087080946 title "Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema" @default.
• W3087080946 cites W129442478 @default.
• W3087080946 cites W1540429588 @default.
• W3087080946 cites W1988578052 @default.
• W3087080946 cites W2012767544 @default.
• W3087080946 cites W2041540648 @default.
• W3087080946 cites W2073333705 @default.
• W3087080946 cites W2073981790 @default.
• W3087080946 cites W2109608126 @default.
• W3087080946 cites W2151429375 @default.
• W3087080946 cites W2305388866 @default.
• W3087080946 cites W2518027570 @default.
• W3087080946 cites W2592307723 @default.
• W3087080946 cites W2599824295 @default.
• W3087080946 cites W2725025256 @default.
• W3087080946 cites W2728846663 @default.
• W3087080946 cites W2782889067 @default.
• W3087080946 cites W2783677252 @default.
• W3087080946 cites W2788038611 @default.
• W3087080946 cites W2804405688 @default.
• W3087080946 cites W2901538983 @default.
• W3087080946 cites W2913393208 @default.
• W3087080946 cites W4250608650 @default.
• W3087080946 cites W50187013 @default.
• W3087080946 doi "https://doi.org/10.1089/ped.2020.1143" @default.
• W3087080946 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7499895" @default.
• W3087080946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32953229" @default.
• W3087080946 hasPublicationYear "2020" @default.
• W3087080946 type Work @default.
• W3087080946 sameAs 3087080946 @default.
• W3087080946 citedByCount "8" @default.
• W3087080946 countsByYear W30870809462021 @default.
• W3087080946 countsByYear W30870809462022 @default.
• W3087080946 countsByYear W30870809462023 @default.
• W3087080946 crossrefType "journal-article" @default.
• W3087080946 hasAuthorship W3087080946A5000365272 @default.
• W3087080946 hasAuthorship W3087080946A5000815038 @default.
• W3087080946 hasAuthorship W3087080946A5005153960 @default.
• W3087080946 hasAuthorship W3087080946A5009663015 @default.
• W3087080946 hasAuthorship W3087080946A5023011562 @default.
• W3087080946 hasAuthorship W3087080946A5051845249 @default.
• W3087080946 hasAuthorship W3087080946A5052789300 @default.
• W3087080946 hasAuthorship W3087080946A5053619303 @default.
• W3087080946 hasAuthorship W3087080946A5058969386 @default.
• W3087080946 hasAuthorship W3087080946A5073049397 @default.
• W3087080946 hasAuthorship W3087080946A5074941284 @default.
• W3087080946 hasAuthorship W3087080946A5084508450 @default.
• W3087080946 hasBestOaLocation W30870809461 @default.
• W3087080946 hasConcept C126322002 @default.
• W3087080946 hasConcept C141071460 @default.
• W3087080946 hasConcept C142724271 @default.
• W3087080946 hasConcept C16005928 @default.
• W3087080946 hasConcept C187212893 @default.
• W3087080946 hasConcept C197934379 @default.
• W3087080946 hasConcept C204787440 @default.
• W3087080946 hasConcept C27081682 @default.
• W3087080946 hasConcept C2777482430 @default.
• W3087080946 hasConcept C2777788586 @default.
• W3087080946 hasConcept C2777995640 @default.
• W3087080946 hasConcept C2779931649 @default.
• W3087080946 hasConcept C2780886150 @default.
• W3087080946 hasConcept C71924100 @default.
• W3087080946 hasConceptScore W3087080946C126322002 @default.
• W3087080946 hasConceptScore W3087080946C141071460 @default.
• W3087080946 hasConceptScore W3087080946C142724271 @default.
• W3087080946 hasConceptScore W3087080946C16005928 @default.
• W3087080946 hasConceptScore W3087080946C187212893 @default.
• W3087080946 hasConceptScore W3087080946C197934379 @default.
• W3087080946 hasConceptScore W3087080946C204787440 @default.
• W3087080946 hasConceptScore W3087080946C27081682 @default.
• W3087080946 hasConceptScore W3087080946C2777482430 @default.
• W3087080946 hasConceptScore W3087080946C2777788586 @default.
• W3087080946 hasConceptScore W3087080946C2777995640 @default.
• W3087080946 hasConceptScore W3087080946C2779931649 @default.
• W3087080946 hasConceptScore W3087080946C2780886150 @default.
• W3087080946 hasConceptScore W3087080946C71924100 @default.
• W3087080946 hasIssue "3" @default.
• W3087080946 hasLocation W30870809461 @default.
• W3087080946 hasLocation W30870809462 @default.
• W3087080946 hasOpenAccess W3087080946 @default.
• W3087080946 hasPrimaryLocation W30870809461 @default.
• W3087080946 hasRelatedWork W1972013002 @default.

• next